buy medicine online indiamedicine onlineloading...


    Information about Ribavirin

    Ribavirin uses

    Ribavirin is used in the treatment of chronic hepatitis C virus (HCV) infection. It is used in combination with interferon.

    How ribavirin works

    Ribavirin is an antiviral medication. It prevents the multiplication of virus in human cells. This stops the virus from producing new viruses and clears up your infection.

    Common side effects of ribavirin

    Headache, Muscle pain, Weakness, Fatigue, Fever
    Content Details
    Written By
    Dr. Sakshi Sharma
    Reviewed By
    Dr. Ashish Ranjan
    MD (Pharmacology), MBBS
    Last updated on:
    18 Feb 2020 | 05:21 PM (IST)
    Want to know more?
    Read Our Editorial Policy

    Available Medicine for Ribavirin

    • ₹95 to ₹313
      Lupin Ltd
      3 variant(s)
    • ₹1175
      Fulford India Ltd
      1 variant(s)
    • ₹750
      Zydus Cadila
      1 variant(s)
    • ₹611
      United Biotech Pvt Ltd
      1 variant(s)
    • ₹81 to ₹226
      Lupin Ltd
      3 variant(s)
    • ₹3600
      Aprazer Healthcare Pvt Ltd
      1 variant(s)
    • ₹535
      Virchow Biotech Pvt Ltd
      1 variant(s)
    • ₹2100
      Dr Reddy's Laboratories Ltd
      1 variant(s)
    • ₹120
      Hetero Drugs Ltd
      1 variant(s)
    • ₹1666
      1 variant(s)

    Frequently asked questions for Ribavirin


    Q. How does Ribavirin work?

    Ribavirin belongs to a class of antiviral medications called nucleoside analogues. It decreases the amount of Hepatitis C virus in the body by blocking its growth, resulting in less liver damage and improved liver function

    Q. What are the severe side effects of Ribavirin?

    Ribavirin may cause anemia that can worsen any heart problems and can cause a heart attack that can be life-threatening. Call your doctor immediately in case you experience excessive tiredness, pale skin, headache, dizziness, confusion, fast heartbeat, weakness, shortness of breath, or chest pain.

    Content on this page was last updated on 18 February, 2020, by Dr. Varun Gupta (MD Pharmacology)